EHR Alert + Structured Communication for Pneumonia
(UP-CAPTAIn Trial)
Trial Summary
Do I have to stop taking my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications. However, since the study focuses on antibiotic use, you may need to adjust your antibiotic treatment based on the trial's findings.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on improving antibiotic use for pneumonia, so it's best to discuss your current medications with the trial team.
What data supports the idea that EHR Alert + Structured Communication for Pneumonia is an effective treatment?
The available research shows that electronic alert systems can improve communication of critical test results, which is important for patient safety. One study found that these systems help ensure that important test results are communicated effectively among healthcare providers. Another study highlighted that computer-generated alerts can prompt reviews of antibiotic use in hospitals, which can lead to better management of treatments. These findings suggest that EHR Alert + Structured Communication can enhance the effectiveness of pneumonia treatment by improving communication and management of care.12345
What data supports the effectiveness of the treatment Electronic alert, Structured communication of test results, Structured Communication of Test Results, Antimicrobial Stewardship Team Intervention for pneumonia?
Research shows that electronic alert systems can improve communication of critical test results, which is important for patient safety. Additionally, computer-generated alerts prompting review of antibiotic use have been shown to impact antibiotic use in hospitals, suggesting that similar systems could help manage pneumonia treatment effectively.12345
What safety data exists for EHR alerts and structured communication for pneumonia?
The research does not directly address safety data for EHR alerts and structured communication specifically for pneumonia. However, it discusses the use of electronic alert systems in healthcare settings, highlighting their role in improving communication of critical test results and medication safety. The studies suggest that while these systems can enhance patient safety by ensuring timely communication and monitoring, there is a risk of alert fatigue among clinicians, which could potentially impact their effectiveness.34678
Is the EHR Alert + Structured Communication for Pneumonia safe for humans?
Is the treatment in the trial 'EHR Alert + Structured Communication for Pneumonia' promising?
How does the EHR Alert + Structured Communication treatment for pneumonia differ from other treatments?
The EHR Alert + Structured Communication treatment for pneumonia is unique because it uses electronic health record (EHR) alerts to improve communication and coordination among healthcare providers, ensuring timely and effective management of pneumonia. This approach focuses on enhancing the workflow and communication processes rather than directly altering the medical treatment itself.368910
What is the purpose of this trial?
The goal of this prospective randomized study is to improve antibiotic use among hospitalized patients with suspected pneumonia. An alert was built into the electronic health record to guide use of diagnostic testing based on probability of bacterial pneumonia. Patients with test results suggesting viral infection will be randomized to either: (1) receive a structured communication from the antimicrobial stewardship team to de-escalate antibiotics or (2) usual care.
Research Team
Daniel J. Morgan, MD, MS
Principal Investigator
University of Maryland, Baltimore
Eligibility Criteria
This trial is for adult patients at two Maryland medical centers who are hospitalized with suspected community-acquired respiratory infections and have test results that may indicate a viral infection. They must be on antibiotics and not just have cold symptoms.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Randomization and Intervention
Patients with test results suggesting viral infection are randomized to receive either structured communication from the antimicrobial stewardship team or usual care.
Follow-up
Participants are monitored for safety outcomes including length of stay, readmissions, hospital-free days, and mortality.
Treatment Details
Interventions
- Electronic alert
- Structured communication of test results
Find a Clinic Near You
Who Is Running the Clinical Trial?
Jonathan Baghdadi
Lead Sponsor
Centers for Disease Control and Prevention
Collaborator